Dr. Nicolas Singewaldsingewald-nicolas--hp-4


Associate Professor
Email: nicolas.singewald@uibk.ac.at
Phone: +43-(0)512-507 - 58802
Fax: +43-(0)512-507 - 58899

Neuropharmacology - Group

For publications in Pubmed click here

For citations in Google Scholar click here

ORCID ID: https://orcid.org/0000-0002-0166-3370






Short Curriculum
1984 Pharmacy Degree: "Magister der Pharmazie"
1984 - 1989 PhD in Pharmaceutical Chemistry/Drug Development
1988 National service at the Military Hospital Innsbruck
1989 - 1996 Postdoc, Department of Pharmacology and Toxicology, University of Innsbruck
1996 Habilitation "In vivo release of endogenous monoamine- and amino acid neurotransmitters in medullary and supramedullary brain areas"
1996 Associate Professor for Pharmacology and Toxicology
1998 - 1999 Schroedinger Fellowship at the University of Oxford, UK, Department of Clinical Pharmacology, Prof. Grahame-Smith, Dr. Trevor Sharp
1999 - 2001 Interimistic head of the Department of Pharmacology and Toxicology, University of Innsbruck
2002 Head of Neuropharmacology unit at the Department of Pharmacology and Toxicology, LFU Innsbruck


Teaching Experience
1991 - 2003 Pharmacology, Toxicology and Bromatology (Lectures and courses)
Computer-supported Lecture in Pharmacology
Methods and Techniques in Pharmacological Science (Lecture and courses)
1999 - 2001 "Pharmacology" (main course)
since 2000 Stem Cells and Gene Therapy (Lecture)
Molecular and pharmacological analytics (course)
Selected chapters in Pharmacology: Neuropharmacology (Main lecture)
General Pharmacology (Course)
since 2003 Postgraduate course: "Behavioural models in Neuroscience"
since 2011 Anatomy, Physiology & Pathophysiology, Research Techniques (Lecture)
since 2018 Medication Therapy and Clinical Pharmacy (Lecture)
Patient-oriented Aspects of Medication Therapy (Lecture and course)


Recent Grant Support
  • Neurobiology of anxiety in autism spectrum disorders (FWF FG 2022-2026)
  • Role of microglial/myeloid system in inborn anxiety and comorbid depression (FWF 2019-2024)
  • Doctoral Programme W1206 " Signal processing in Neurons” (FWF 2017 – 2021)
  • Dopamine-ghrelin interactions as novel Targets for Treatment-resistant anxiety (FWO/FWF, 2016-2020)
  • Epigenetic mechanisms in aberrant memory regulation  (FWF SFB44  2015-19)
  • Europ. Pat. Nr. 87106381.4: Klötzer W, Link H, Müssner R, Schiestl W, Singewald N: 1.3-Disubstituierte Imidazoliumsalze
  • Europ. Pat. Nr. 88103746.9: Klötzer W, Montavon M, Müssner R, Singewald N: Benzyliden-amino-, benzylamino und benzoylamino-imidazolderivate



nach oben

Nach oben scrollen